Latest Organofluorides Stories
Researchers at MIT have developed a new device which uses nanoparticles to block the genes that confers drug resistance, offering a new way to prevent chemotherapy and other treatments from losing their effectiveness in treating cancer over time.
A study published in The Oncologist on February 26, 2015, challenges the role of fluorescence in situ hybridization (FISH) testing as the current gold standard for detecting EML4-ALK rearrangements
Pharmaceutical manufacturer, Johnson & Johnson, loses $2.5 million verdict for marketing of Risperdal, a potent antipsychotic that caused female breast growth in a young boy the case revealed.
LONDON, Feb. 26, 2015 /PRNewswire/ -- Kidneys are among the most crucial organs of the human body.
- Proceeds to Support Phase II Clinical Development of SB 9200 Against Hepatitis B - MILFORD, Mass., Feb.
-- Phase 1 Studies Confirm Superior Safety Profile of MRX-I Over Zyvox® -- HAYWARD, Calif. and SHANGHAI, Feb.
ReportsnReports.com adds “Global and Chinese Pitavastatin calcium Industry, 2009-2019 Market Research Report” to its store. Dallas, TX (PRWEB) February 23,
The Risperdal trial currently underway in the Pennsylvania mass tort, where Bernstein Liebhard LLP is actively filing claims, is the first to involve gynecomastia, and could provide insight into
RALEIGH, N.C., Feb. 17, 2015 /PRNewswire/ -- Sprout Pharmaceuticals announced today that it has resubmitted a New Drug Application (NDA) to the U.S.
The Firm is representing numerous clients in Risperdal lawsuits that allege gynecomastia in the Philadelphia Court of Common Pleas. New York, NY (PRWEB) February